Skip to content
Psychiatrist.com Logo
  • JCP
  • PCC
  • News
  • CME
  • About
  • Authors & Reviewers
  • Sign In
  • Subscribe
Advanced Search

Menu

  • JCP
  • PCC
  • News
  • CME
  • About
  • Authors & Reviewers
  • Sign In
  • Subscribe
Sign in Subscribe

Clinical Topics

View All
  • Addiction
  • ADHD
  • Anxiety
  • Bipolar Disorder
  • Depression
  • Emerging Approaches in Schizophrenia
  • Movement Disorders
  • Neurology
  • OCD
  • Psychopharmacology
  • PTSD and Trauma
  • Schizophrenia/Schizoaffective Disorders
  • Sleep
  • Tardive Dyskinesia
  • View All

Collections

View All
  • Academic Highlights
  • Auvelity: Information from Industry
  • Banner Alzheimer’s Institute
  • Clinical & Practical Psychopharmacology
  • Early Career Psychiatrists
  • Focus on Childhood and Adolescent Mental Health
  • Focus on Geriatric Psychiatry
  • Focus on Psychotherapy
  • Focus on Suicide
  • Focus on Psychosis
  • Focus on Women’s Mental Health
  • Rounds in the General Hospital
  • View All
Back to top Open menu arrow
Download Free PDF

Save Save

Share Share

Cite Cite

Reprints
Sections
No sections available
Primary Care Companion for CNS Disorders Primary Care Companion for CNS Disorders

The Primary
Care Companionfor CNS Disorders

Access icon
Addiction

Letter to the Editor October 15, 2004

A Case of Rhabdomyolysis After Intravenous Heroin Use

Subramoniam Madhusoodanan, MD ; Sanjay Gupta, MD ; Gregoria Calleja, MD ; Olivera Bogunovic, MD ; Ronald Brenner, MD

Prim Care Companion J Clin Psychiatry 2004;6(5):221-222

Article Abstract

Letter to the Editor

A Case of Rhabdomyolysis After Intravenous Heroin Use

Download Free PDF

This PDF is free for all visitors!

Save Save

Share Share

Cite Cite

Related News Articles

Caregiver Alcohol Use Drives Up Child Abuse Risk Smartphones Are Distracting. But They Don’t Hurt Our Productivity. No Surprise. Unplugging From Your Smartphone Is Good For You.

Sponsored

PsychCase360: Choosing the Right Long-Acting Injectable for Patients With Schizophrenia
Explore two real-world schizophrenia cases with Roueen Rafeyan, MD and Melissa Vitale, PMHNP as they discuss challenges with medication adherence, transitioning to long-acting injectables (LAIs), and personalizing treatment strategies to improve patient outcomes.

Related JCP Articles

Intranasal Oxytocin and Alcohol Behavioral Couple Therapy Defense Mechanisms and Common Psychiatric Disorders Opioid Use Disorder in Sexually and Gender Diverse Populations: Can We Do Better?

Related PCC Articles

Secondary Delusional Infestation in a Male with a History of Polysubstance Use Revisiting Ayahuasca: Vine of the Soul of the Amazon Cannabis Withdrawal Psychosis

Vol 27 • 2025 • Number 2

Read the Current Issue

Original Research

What Internists and Neurologists Know and Think About Catatonia

Original Research

Psychological Morbidities in Hospital Staff During Nipah Virus

Systematic Review

Exercise and Fibromyalgia Pain

Rounds in the General Hospital

Managing Anxiety, Agitation, and Pain in Critically Ill Patients

Review Article

Quality Indicators in Community Mental Health Services: A Scoping Review

Case Report

Is My Patient Diverting Their Lorazepam?

View current Issue

Related Articles

JCP
Detecting Misuse of Prescription Opioids
Letter to the Editor

Detecting Misuse of Prescription Opioids

October 21, 2024

The authors discuss the difficulty in screening for opioid misuse and the need for clinicians to gain confidence in initiating difficult discussions with patients on long-term opioid treatment.
Vania Modesto-Lowe , Alyssa Crispino , Michael Salley
PCC
Harm Reduction in Adolescent Inhalant Use
Letter to the Editor

Harm Reduction in Adolescent Inhalant Use

October 15, 2024

The authors discuss harm reduction efforts targeting inhalant use in the adolescent population.
Vania Modesto-Lowe , Roseane Rodrigues , Deanna Sgambato
PCC
Zeroing in on Xylazine
Letter to the Editor

Zeroing in on Xylazine

August 15, 2024

Dr Kaur and colleagues discuss the need to raise awareness among US public and health care professionals about xylazine due to its infiltration into the illicit drug supply.
Jasleen Kaur , Megan Nosol , Vania Modesto-Lowe

Watch the New PsychCase360

Explore two real-world schizophrenia cases

Subscribe to read
more articles

Subscribe
The Journal of Clinical Psychiatry
The Primary Care Companion for CNS Disorders

ELSEWHERE:

  • ABOUT
  • ADVERTISERS
  • MEDIA RELATIONS
  • REPRINTS & PERMISSIONS
  • CONTACT US
  • CUSTOMER SUPPORT

FOLLOW US:

  • X
  • FACEBOOK
  • INSTAGRAM
  • LINKEDIN
  • SIGN IN

  • JOIN THE EMAIL LIST


SUBSCRIBE NOW
An image of the Psychiatrist.com logo mark
  • Privacy Policy
  • Terms of Use
  • Physicians Postgraduate Press, Inc.
  • JCP ISSN: Online 1555-2101, Print 0160-6689
  • PCC ISSN: Online 2155-7780, Print 2155-7772
  • MedFair.com US Patent No. 684794
  • © Copyright 2025 | Physicians Postgraduate Press, Inc. | LifeLong Learning For Clinicians
  • Sitemap